Synergistic Interaction of the Class IIa HDAC Inhibitor CHDI0039 with Bortezomib in Head and Neck Cancer Cells

In contrast to class I/IIb/pan histone deacetylase inhibitors (HDACi), the role of class IIa HDACi as anti-cancer chemosensitizing agents is less well understood. Here, we studied the effects of HDAC4 in particular and the class IIa HDACi CHDI0039 on proliferation and chemosensitivity in Cal27 and c...

Descripción completa

Detalles Bibliográficos
Autores principales: Schrenk, Christian, Bollmann, Lukas M., Haist, Corinna, Bister, Arthur, Wiek, Constanze, Wecker, Maria, Roth, Dennis, Petzsch, Patrick, Köhrer, Karl, Hamacher, Alexandra, Hanenberg, Helmut, Fluegen, Georg, Kassack, Matthias U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056166/
https://www.ncbi.nlm.nih.gov/pubmed/36982651
http://dx.doi.org/10.3390/ijms24065553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056166/
https://www.ncbi.nlm.nih.gov/pubmed/36982651
http://dx.doi.org/10.3390/ijms24065553

Ejemplares similares